Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
NOT YET RECRUITING
NCT06828289
Rivastigmine Mini-Tablet for Alzheimer's Disease
Sponsor: Peking University First Hospital
View on ClinicalTrials.gov
Summary
The objective of this study is to evaluate the efficacy and safety of rivastigmine mini-tablets in individuals diagnosed with mild to moderate Alzheimer's disease (AD).
Official title: Observational Study of Rivastigmine Mini-Tablet in Patients with Alzheimer's Disease
Key Details
Gender
All
Age Range
50 Years - Any
Study Type
OBSERVATIONAL
Enrollment
1000
Start Date
2025-02-28
Completion Date
2026-12-31
Last Updated
2025-02-20
Healthy Volunteers
No
Conditions
Interventions
DRUG
Rivastigmine Mini-Tablet
Treatment group: Rivastigmine Mini-Tablet
DRUG
Donepezil Hydrochloride
Control group: Donepezil Hydrochloride